Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review

被引:47
作者
Casseres, Rachel G. [1 ,2 ]
Kahn, Jared S. [1 ,2 ]
Her, Min Ji [1 ]
Rosmarin, David [1 ,2 ]
机构
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
[2] Tufts Med Ctr, Dept Dermatol, Boston, MA 02111 USA
关键词
D O I
10.1016/j.jaad.2018.12.017
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:265 / 267
页数:4
相关论文
共 3 条
[1]   Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa [J].
Gulliver, W. P. ;
Jemec, G. B. E. ;
Baker, K. A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (07) :911-914
[2]   Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial [J].
Kimball, Alexa B. ;
Kerdel, Francisco ;
Adams, David ;
Mrowietz, Ulrich ;
Gelfand, Joel M. ;
Gniadecki, Robert ;
Prens, Errol P. ;
Schlessinger, Joel ;
Zouboulis, Christos C. ;
van der Zee, Hessel H. ;
Rosenfeld, Marie ;
Mulani, Parvez ;
Gu, Yihua ;
Paulson, Susan ;
Okun, Martin ;
Jemec, Gregor B. E. .
ANNALS OF INTERNAL MEDICINE, 2012, 157 (12) :846-+
[3]   Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa [J].
Schlapbach, Christoph ;
Haenni, Tanja ;
Yawalkar, Nikhil ;
Hunger, Robert E. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (04) :790-798